We live in an era of unprecedented innovation for people living with cancer. Yet, there is no value from innovation if patients for whom it is intended, cannot have access to it.
For cancer patients, Every Day Counts… but significant differences exist in patient access to innovative oncology therapies in Europe. Accelerating time to patient access will be critical to beat cancer in Europe.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.